BSVO vs. EBS

In the year-to-date period, BSVO achieves a -12.15% return, which is significantly higher than EBS's -42.36% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for EA Bridgeway Omni Small-Cap Value ETF (BSVO) and Emergent BioSolutions Inc. (EBS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BSVO Sharpe Ratio is -0.26, which is lower than the EBS Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of BSVO and EBS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

BSVO's dividend yield for the trailing twelve months is around 1.83%, while EBS has not paid dividends to shareholders.

The maximum BSVO drawdown since its inception was -19.13%, smaller than the maximum EBS drawdown of -98.89%. Use the drawdown chart below to compare losses from any high point for BSVO and EBS. For additional features, visit the drawdowns tool.

The current volatility for EA Bridgeway Omni Small-Cap Value ETF (BSVO) is 4.99%, while Emergent BioSolutions Inc. (EBS) has a volatility of 26.79%. This indicates that BSVO experiences smaller price fluctuations and is considered to be less risky than EBS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.